Friday, November 21, 2014 10:16:29 PM
The partnership between the Theranostics laboratory and the Auckland Bioengineering Institute (ABI) is a strategic alliance for Vantage Health Inc, through which the lab will act as principal investigators for Vantage in the areas of mobile strep detection, mobile virus detection and other related areas including breath sample conditioning methodologies.
Recent VNTH News
- Form 8-K - Current report • Edgar (US Regulatory) • 09/13/2023 09:30:06 PM
FEATURED Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • May 7, 2024 8:51 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM